NYSE$HCA

HCA Holdings Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

HCA Healthcare's Q4 2021 earnings were released, showcasing revenue of $15.064 billion and net income of $1.814 billion.

HCA Healthcare reported a revenue increase to $15.064 billion for Q4 2021, compared to $14.293 billion in Q4 2020. Net income attributable to HCA Healthcare, Inc. increased to $1.814 billion, or $5.75 per diluted share, compared to $1.426 billion, or $4.13 per diluted share, in the same quarter of the previous year. The company also provided 2022 guidance, increased capital spending, authorized an additional share repurchase program, and increased the quarterly dividend.

  • Revenues totaled $15.064 billion.
  • Net income attributable to HCA Healthcare, Inc. totaled $1.814 billion, or $5.75 per diluted share.
  • Adjusted EBITDA totaled $3.149 billion.
  • Cash flows provided by operating activities totaled $2.443 billion.

Headline financials

Total Revenue

$15.1B

Previous: $14.3B+5.4%
EPS (adj)

$4.42

Previous: $4.13+7.0%
Admissions

514.7K

Previous: 521.9K-1.4%
Number of Hospitals

182

Previous: 185-1.6%
Licensed Beds at End of Period

48.8K

Previous: 49.3K-0.9%
Occupancy

70.2%

Previous: 69.1%+1.6%
Average Length of Stay (days)

5.232

Previous: 5.123+2.1%
Capital Expenditures

$1.19B

Previous: $748M+59.4%
Free Cash Flow

$1.25B

Previous: -$4.33B+128.9%
Net Income

$2.01B

Previous: $1.69B+18.4%
Operating Income

$2.59B

Previous: $2.07B+24.8%
Gross Profit

$12.7B

Previous: $11.9B+6.1%
Cash & Equivalents

$1.45B

Previous: $1.79B-19.1%
Total Assets

$50.7B

Previous: $47.5B+6.8%
Stock-Based Comp

$99M

Previous: $133M-25.6%

Revenue & EPS history

HCA · Revenue · Quarterly

$15.1B

Q4 2021+5.4%vs Q4 2020
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Forward guidance

HCA Healthcare issued its estimated guidance for 2022, projecting revenues between $60.0 to $62.0 billion and EPS (diluted) between $18.40 to $19.20 per diluted share.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+2.9%

Avg return

30 days after

47%

31 / 66 earnings

Positive

+16.1%

Q2 2020

Best reaction

-21.9%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.2%-8.3%-16.8%
Q4 2025+6.2%+3.4%+11.3%
Q3 2025+1.5%+6.4%+11.6%
Q2 2025+0.8%+3.1%+3.8%
Q1 2025-4.0%+1.1%+10.3%
Q4 2024-3.8%+0.7%-2.7%
Q3 2024-10.6%-9.5%-18.5%
Q2 2024+5.7%+9.0%+17.7%
Q1 2024-0.9%-1.5%+1.5%
Q4 2023+6.3%+7.9%+8.7%
Q3 2023-6.5%-6.5%+5.0%
Q2 2023-3.2%-2.9%-3.2%
Q1 2023+5.7%+2.7%+4.3%
Q4 2022-0.6%+2.6%-2.2%
Q3 2022+0.8%+4.3%+10.3%
Q2 2022+9.6%+12.9%+18.6%
Q1 2022-21.9%-21.2%-24.0%
Q4 2021-1.4%-1.1%+5.5%
Q3 2021-7.0%-5.6%-8.1%
Q2 2021+14.5%+14.2%+13.3%
Q1 2021+2.5%+0.7%+4.5%
Q4 2020+3.7%+5.9%+5.6%
Q3 2020-4.4%-9.3%+12.5%
Q2 2020+16.1%+14.6%+21.2%
Q1 2020-5.4%-2.4%-2.2%
Q4 2019+2.6%-2.0%-10.1%
Q3 2019+6.2%+5.3%+10.3%
Q2 2019-8.7%-13.0%-17.4%
Q1 2019-1.1%+0.2%-2.3%
Q4 2018+5.6%+6.1%+5.5%
Q3 2018+3.5%+4.2%+12.0%
Q2 2018+14.9%+14.7%+21.4%
Q1 2018+2.1%+1.9%+7.7%
Q4 2017+3.6%+2.1%+1.9%
Q3 2017+0.9%+0.3%+11.6%
Q2 2017-5.2%-6.6%-7.9%
Q1 2017-1.2%-0.4%-0.1%
Q4 2016+3.4%+5.7%+10.2%
Q3 2016-2.1%-4.5%-9.6%
Q2 2016-1.1%-3.8%-4.8%
Q1 2016-1.7%
Q4 2015+3.1%
Q3 2015-0.1%
Q2 2015-2.8%
Q1 2015-1.2%
Q4 2014-1.7%
Q3 2014-2.1%
Q2 2014+4.1%
Q1 2014-1.2%
Q4 2013-1.0%
Q3 2013-5.1%
Q2 2013+0.1%
Q1 2013+3.8%
Q4 2012-1.1%
Q3 2012+8.0%
Q2 2012+1.1%
Q1 2012-1.1%
Q4 2009+3.5%
Q4 2011+3.5%
Q3 2011+2.6%
Q3 2010+2.6%
Q2 2011-20.6%
Q2 2010-20.6%
Q1 2011-0.2%
Q1 2010-0.2%
Q4 2010-0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro